Medication options and role

Social anxiety disorder is common. The 1-year point prevalence rate is about 7% and the estimated lifetime prevalence about 12%.

And social anxiety disorder can have a real effect on a patient’s life.

To find out more about this condition, please do listen to this BMJ Best Practice podcast interview with Professor Craig Sawchuk of the Department of Psychiatry and Psychology, Mayo Clinic.

Craig is also the author of our BMJ Best Practice topic on this subject.

For more on social anxiety disorder, visit BMJ Best Practice.

Competing interests: None